|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016884,
umls-concept:C0029118,
umls-concept:C0035015,
umls-concept:C0039593,
umls-concept:C0205171,
umls-concept:C0205178,
umls-concept:C0449435,
umls-concept:C0681842,
umls-concept:C1268930,
umls-concept:C1510438,
umls-concept:C1548437,
umls-concept:C1882923,
umls-concept:C2348792
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-2-17
|
|
pubmed:abstractText |
Current assays and tests that are used to determine the degree of immunosuppression in renal transplant recipients are suboptimal. The ImmuKnow assay (Cylex), a measure of intracellular CD4+ T cell ATP release proposed as a means to quantify cell-mediated immunity in transplant recipients, could be considered as a potential tool to identify patients at risk for opportunistic infections (OI) or acute rejection (AR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1555-905X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
423-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21088287-Acute Disease,
pubmed-meshheading:21088287-Adenosine Triphosphate,
pubmed-meshheading:21088287-Adult,
pubmed-meshheading:21088287-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21088287-Case-Control Studies,
pubmed-meshheading:21088287-Chi-Square Distribution,
pubmed-meshheading:21088287-Colorado,
pubmed-meshheading:21088287-Drug Monitoring,
pubmed-meshheading:21088287-Female,
pubmed-meshheading:21088287-Graft Rejection,
pubmed-meshheading:21088287-Humans,
pubmed-meshheading:21088287-Immunologic Tests,
pubmed-meshheading:21088287-Immunosuppressive Agents,
pubmed-meshheading:21088287-Kidney Transplantation,
pubmed-meshheading:21088287-Logistic Models,
pubmed-meshheading:21088287-Male,
pubmed-meshheading:21088287-Middle Aged,
pubmed-meshheading:21088287-Odds Ratio,
pubmed-meshheading:21088287-Opportunistic Infections,
pubmed-meshheading:21088287-Predictive Value of Tests,
pubmed-meshheading:21088287-Retrospective Studies,
pubmed-meshheading:21088287-Risk Assessment,
pubmed-meshheading:21088287-Risk Factors,
pubmed-meshheading:21088287-Time Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.
|
|
pubmed:affiliation |
Transplant Center, Department of Pediatrics, University of Colorado, Denver, CO, USA.
|
|
pubmed:publicationType |
Journal Article
|
